Switzerland to India: Tiotropium Import Trade Route

The Switzerland to India Tiotropium corridor is one of India's established pharmaceutical import routes from Switzerland, with 1 shipments documented worth a combined $2.3K USD. The route is dominated by ALVOGEN INC , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Switzerland's tiotropium export sector.

Across 1 active Switzerland suppliers, the average shipment value stands at $2.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with tiotropium's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 27.8%, placing it at rank #12 among India's top tiotropium import origins globally.

On the Indian buyer side, key Indian importers include CLIANTHA RESEARCH LIMITED. CLIANTHA RESEARCH LIMITED is the single largest Indian importer with 1 shipments valued at $2.3K USD.

India's tiotropium imports from Switzerland are driven primarily by a handful of large-scale Switzerland manufacturers. ALVOGEN INC with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Switzerland supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ALVOGEN INC — together account for 100% of total trade value on this route. The average shipment value of $2.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, CLIANTHA RESEARCH LIMITED is the largest importer with 1 shipments worth $2.3K USD — representing 100% of all tiotropium imports from Switzerland on this route.